Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI South East AsiaCPhI South East Asia
Not Confirmed
Not Confirmed
16-18 July, 2025
Not Confirmed
Not Confirmed
13-16 July, 2025
Not Confirmed
Not Confirmed
14-15 July, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI South East AsiaCPhI South East Asia
Industry Trade Show
Not Confirmed
16-18 July, 2025
Industry Trade Show
Not Confirmed
13-16 July, 2025
Industry Trade Show
Not Confirmed
14-15 July, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-veranova-carbogen-lead-adc-investments-axplora-polfa-tarchomin-famar-expand-european-footprint
23 Jun 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/06/23/3103185/0/en/ITM-and-Debiopharm-Announce-First-Patient-Imaged-in-New-Study-Arm-of-Phase-1-2-Trial-Evaluating-ITM-94-as-Diagnostic-Agent-for-Clear-Cell-Renal-Cell-Carcinoma-ccRCC.html
12 Jun 2025
// CONTRACTPHARMA
https://www.contractpharma.com/breaking-news/debiopharm-alkyon-therapeutics-to-research-radioligand-therapies/
12 Jun 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250612596008/en/Debiopharm-and-Alkyon-Therapeutics-Announce-Research-Collaboration-to-Advance-the-Next-Generation-of-Radioligand-Therapies
29 May 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250529299590/en/Debiopharm-Ignites-Oncology-Innovation-With-Clinical-and-Translational-Data-on-Debio-0123-at-the-2025-ASCO-Annual-Meeting-in-Chicago
28 May 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250528860354/en/CARB-X-Grants-Debiopharm-an-Additional-%2412.3-Million-to-Advance-Development-of-Novel-Antibiotic-Against-Gonorrhea
24 Apr 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250424538240/en/Debiopharm-and-Oncodesign-Services-Launch-Strategic-Collaboration-to-Propel-Radiopharmaceuticals-in-Preclinical-Research
ABOUT THIS PAGE
Debiopharm is a supplier offers 4 products (APIs, Excipients or Intermediates).
Find a price of Oxaliplatin bulk with CEP offered by Debiopharm
Find a price of Triptorelin Pamoate bulk with DMF offered by Debiopharm
Find a price of Oxaliplatin bulk offered by Debiopharm
Find a price of Triptorelin Pamoate bulk offered by Debiopharm